GSK2606414 Mechanism of Action: PERK Inhibition in Neuronal Cells Research

GSK2606414 MOA:Targeting PERK/UPR Pathway for Neurodegenerative Diseases

🎯 check GSK2606414 product page

GSK2606414 is a specific PERK inhibitor. It affects the PERK/eIF2α/ATF4/CHOP and ISR signaling pathways by blocking PERK and eIF2α phosphorylation, effectively inhibiting ER stress-induced apoptosis, oxidative stress, and extracellular matrix deposition.

Primary Applications and Mechanism of Action